Search Results

There are 167412 results for: content related to: Effektivität und Sicherheit von Rituximab beim Pemphigus: Ergebnisse aus dem Deutschen Register für Autoimmunerkrankungen

  1. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have free access to this content
    Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

    American Journal of Transplantation

    Volume 10, Issue 1, January 2010, Pages: 89–98, N. Kamar, O. Milioto, B. Puissant-Lubrano, L. Esposito, M. C. Pierre, A. Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M. B. Nogier, D. Durand, M. Abbal, A. Blancher and L. Rostaing

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1600-6143.2009.02785.x

  4. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  5. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x

  6. You have free access to this content
    Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 1215–1226, Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P. Garg, Paul Brunetta, Gerald Appel and LUNAR Investigator Group

    Version of Record online : 27 MAR 2012, DOI: 10.1002/art.34359

  7. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  8. You have free access to this content
    Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma

    British Journal of Clinical Pharmacology

    Volume 73, Issue 4, April 2012, Pages: 597–605, David Ternant, Guillaume Cartron, Emilie Hénin, Michel Tod, Pascal Girard and Gilles Paintaud

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1365-2125.2011.04125.x

  9. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  10. You have free access to this content
    Rituximab in the treatment of autoimmune haemolytic anaemia

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 709–719, Chaturaka Rodrigo, Senaka Rajapakse and Lallindra Gooneratne

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12498

  11. Rituximab, an Anti-CD20 Monoclonal Antibody

    Immunotherapy in Transplantation: Principles and Practice

    Bruce Kaplan, Gilbert J. Burckart, Fadi G. Lakkis, Pages: 362–377, 2012

    Published Online : 19 APR 2012, DOI: 10.1002/9781444355628.ch24

  12. Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 1001–1009, Sarit Assouline, Valeria Buccheri, Alain Delmer, Gianluca Gaidano, Christine McIntyre, Michael Brewster, Olivier Catalani, Florence Hourcade-Potelleret, Pakeeza Sayyed and Xavier Badoux

    Version of Record online : 29 JUL 2015, DOI: 10.1111/bcp.12662

  13. Experience with low-dose rituximab in off-label indications at two tertiary hospitals

    Internal Medicine Journal

    Volume 43, Issue 8, August 2013, Pages: 871–882, J. Chay, P. Donovan, L. Cummins, P. Kubler and P. Pillans

    Version of Record online : 6 AUG 2013, DOI: 10.1111/imj.12207

  14. You have free access to this content
    Biologic agents in the treatment of glomerulonephritides

    Nephrology

    Volume 20, Issue 11, November 2015, Pages: 767–787, See Cheng Yeo and Adrian Liew

    Version of Record online : 7 OCT 2015, DOI: 10.1111/nep.12530

  15. You have full text access to this Open Access content
    Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: A multicenter phase II study

    Cancer Science

    Volume 102, Issue 9, September 2011, Pages: 1698–1705, Kensei Tobinai, Tadahiko Igarashi, Kuniaki Itoh, Mitsutoshi Kurosawa, Hirokazu Nagai, Akira Hiraoka, Tomohiro Kinoshita, Naokuni Uike, Michinori Ogura, Shigeru Nawano, Shigeo Mori, Yasuo Ohashi and the IDEC-C2B8 Study Group

    Version of Record online : 8 JUL 2011, DOI: 10.1111/j.1349-7006.2011.02001.x

  16. You have free access to this content
    Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 622–632, Maria W. Greenwald, William J. Shergy, Jeffrey L. Kaine, Marianne T. Sweetser, Kye Gilder and Matthew D. Linnik

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30194

  17. You have free access to this content
    Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody–associated vasculitis

    Arthritis & Rheumatism

    Volume 64, Issue 11, November 2012, Pages: 3760–3769, Rona M. Smith, Rachel B. Jones, Mary-Jane Guerry, Simona Laurino, Fausta Catapano, Afzal Chaudhry, Kenneth G. C. Smith and David R. W. Jayne

    Version of Record online : 27 OCT 2012, DOI: 10.1002/art.34583

  18. Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1918–1926, Jing Li, Jianguo Zhi, Michael Wenger, Nancy Valente, Anna Dmoszynska, Tadeusz Robak, Ranvir Mangat, Amita Joshi and Jennifer Visich

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011430506

  19. Rituximab for the Treatment of Rheumatoid Arthritis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 12, December 2007, Pages: 1702–1710, Arthur A. Schuna

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.12.1702

  20. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2014

    HIV Medicine

    Volume 15, Issue S2, March 2014, Pages: 1–92, Writing Group, Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali, Prof Chris Bunker, Dr Fiona Burns, Dr Duncan Churchill, Mr Simon Collins, Dr Kate Cwynarski, Dr Simon Edwards, Dr Paul Fields, Dr Kate Fife, Dr Eve Gallop-Evans, Dr Shireen Kassam, Dr Ranjababu Kulasegaram, Prof Charles Lacey, Dr Robert Marcus, Dr Sylvia Montoto, Dr Mark Nelson, Dr Tom Newsom-Davis, Dr Chloe Orkin, Ms Kate Shaw, Dr Melinda Tenant-Flowers, Dr Andrew Webb, Dr Sarah Westwell and Mr Matt Williams

    Version of Record online : 14 FEB 2014, DOI: 10.1111/hiv.12136